- Titre
- Toxic death-case after capecitabine + oxaliplatin (XELOX) administration : probable implication of dihydropyrimidine deshydrogenase deficiency
- Créateurs - sans rôle
- Joseph Ciccolini - Clinical Pharmacokinetics Department, La Timone University Hospital, Marseille, FranceCedric Mercier - Medical Oncology Unit. La Timone University Hospital. 235 rue St Pierre, 13385 Marseille, FranceBruno Lacarelle - Clinical Pharmacokinetics Department, La Timone University Hospital, Marseille, FranceLaetitia Dahan - Gastroenterology Unit. La Timone University Hospital, Marseille, FranceAlexandre Evrard - Clinical Biochemistry and Toxicology Department. Caremeau General Hospital, Nimes, FranceJean-Christophe Boyer - Clinical Biochemistry and Toxicology Department. Caremeau General Hospital, Nimes, FranceKarine Richard - Gastroenterology Unit. La Timone University Hospital, Marseille, FranceJean-Philippe Dales - Anatomopathology Department. Northern School of Medicine, Marseille, FranceAlain Durand - Clinical Pharmacokinetics Department, La Timone University Hospital, Marseille, FranceGerard Milano - Clinical Pharmacokinetics Department, La Timone University Hospital, Marseille, FranceJean-Francois Seitz - Gastroenterology Unit. La Timone University Hospital, Marseille, France
- Détails de publication
- Cancer chemotherapy and pharmacology, Vol.58(2), pp.272-275
- Éditeur
- Springer
- Nombre de pages
- 4
- Identifiants
- 99162675709311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration : probable implication of dihydropyrimidine deshydrogenase deficiency
Cancer chemotherapy and pharmacology, Vol.58(2), pp.272-275
08/2006
PMID: 16292536
Indicateurs
1 Consultations de la notice